Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents

scientific article published on February 9, 2013

Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJMECH.2013.01.054
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0223523413000822?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0223523413000822?httpAccept=text/xml
P698PubMed publication ID23567949
P5875ResearchGate publication ID236139439

P2093author name stringSaman Raza
W. Haq
Arvind K. Srivastava
Daya S. Srivastava
Swayam P. Srivastava
S. B. Katti
P2860cites workDiscovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)Q27644265
(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agentsQ28372550
A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese ratsQ33481431
GLP-1 for type 2 diabetesQ33794098
PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancerQ34106716
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitusQ34461583
Adipogenesis: forces that tip the scalesQ34467039
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysisQ34686103
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetesQ35085591
Diabetes mellitus: pathogenesis and treatment strategiesQ35855859
Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacologyQ35975460
Thiazolidinediones: antidiabetic drugs with cardiovascular effectsQ36715633
Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated ReceptorsQ37014815
The effect of thiazolidinediones on BMD and osteoporosisQ37241742
The genetics of diabetes susceptibility in miceQ38688754
Stimulatory effect of Ceriops tagal on hexose uptake in L6 muscle cells in culture.Q39969825
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucoQ40445932
Troglitazone induces GLUT4 translocation in L6 myotubes.Q40808543
Isoxazolidine-3,5-dione and Noncyclic 1,3-Dicarbonyl Compounds as Hypoglycemic AgentsQ41032669
Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonistsQ42798737
Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities.Q42806881
Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonistsQ43238006
Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent modelsQ43266104
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonistsQ44924358
Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazoneQ46399196
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studiesQ46922580
Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) miceQ51630317
The synthesis of BRL 49653 - a novel and potent antihyperglycaemic agentQ56384774
Laboratory animals exhibiting obesity and diabetes syndromesQ67542769
Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compoundsQ68033178
Benzyloxazolidine-2,4-diones as potent hypoglycemic agentsQ70156227
Novel Euglycemic and Hypolipidemic Agents. 1Q74511094
P407language of work or nameEnglishQ1860
P921main subject(RS)-rosiglitazoneQ424771
P304page(s)611-620
P577publication date2013-02-09
P1433published inEuropean Journal of Medicinal ChemistryQ3008624
P1476titleThiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents
P478volume63

Reverse relations

Q38837346Dose-related antihyperglycemic and hypolipidemic effects of two novel thiazolidin-4-ones in a rodent model of metabolic syndromecites workP2860

Search more.